Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.
Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page
- Check3 days agoChange DetectedLocations where the trial is conducted were updated, with additions of numerous site locations and related topics such as MedlinePlus Genetics. Several location-specific entries were removed.SummaryDifference2%
- Check10 days agoChange DetectedRemoved the related topics 'Lung cancer' and 'MedlinePlus Genetics' from the page's related topics section.SummaryDifference0.1%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded related topics Lung cancer and MedlinePlus Genetics to the page, providing additional context and external-resource links.SummaryDifference0.1%
- Check31 days agoChange DetectedRevision: v3.3.2 is now shown on the page. The deletions remove references to Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.2.0.SummaryDifference0.1%
- Check39 days agoChange DetectedThe page no longer shows the lapse in government funding notice and related operating-status guidance (cc.nih.gov / opm.gov). This notice was previously displayed near the top of the page.SummaryDifference0.2%
- Check53 days agoChange DetectedTwo screenshots show the same page with no changes to the study details, eligibility criteria, or outcomes; any detected differences appear to be minor formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.